miR-96-5p regulates myocardial infarction-induced cardiac fibrosis via Smad7/Smad3 pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-96-5p regulates myocardial infarction-induced cardiac fibrosis via Smad7/Smad3 pathway

Published:2022-12-01 Issue:12 Volume:54 Page:1874-1888
ISSN:1672-9145
Container-title:Acta Biochimica et Biophysica Sinica
language:en
Short-container-title:ABBS

Author:

Gu Huanyu,Duan Yi,Li Shanshan,Wang Qin,Zhen Wen,Zhang Wei,Zhang Yingying,Jiang Min,Wang Chun

Publisher

China Science Publishing & Media Ltd.

Subject

General Medicine,Biochemistry,Biophysics

Link

https://engine.scichina.com/doi/pdf/FA0B513973C84F79940EBE2392455CC2

Reference41 articles.

1. Adams E, McCloy R, Jordan A, Falconer K, Dykes IM. Direct reprogramming of cardiac fibroblasts to repair the injured Heart. J Cardiovasc Dev Dis, 2021, 8:

2. Mia MM, Cibi DM, Ghani SABA, Singh A, Tee N, Sivakumar V, Bogireddi H. Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function. Cardiovasc Res, 2022, 118: 1785-1804.

3. Gan W, Ren J, Li T, Lv S, Li C, Liu Z, Yang M. The SGK1 inhibitor EMD638683, prevents angiotensin II–induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation. Biochim Biophys Acta Mol Basis Dis, 2018, 1864: 1-10.

4. Talman V, Ruskoaho H. Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration. Cell Tissue Res, 2016, 365: 563-581.

5. Park S, Nguyen NB, Pezhouman A, Ardehali R. Cardiac fibrosis: potential therapeutic targets. Transl Res, 2019, 209: 121-137.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Traditional Chinese and Western Medicine on Heart Failure after Myocardial Infarction;Advances in Clinical Medicine;2024

2. MicroRNAs Regulating Signaling Pathways in Cardiac Fibrosis: Potential Role of the Exercise Training;American Journal of Physiology-Heart and Circulatory Physiology;2023-12-08

3. CEBPD REGULATES OXIDATIVE STRESS AND INFLAMMATORY RESPONSES IN HYPERTENSIVE CARDIAC REMODELING;Shock;2023-09-18

4. MicroRNAs in idiopathic inflammatory myopathies: state-of-the-art and future perspectives;Current Opinion in Rheumatology;2023-08-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3